Practise the words
Exerciții: Practica vocabularului. Completează propozițiile folosind noii termeni medicali învățați anterior. Aceste exerciții de engleză consolidează utilizarea corectă a noțiunilor de reglementare farmaceutică.
Практика: Закрепление лексики. Заполните пропуски в предложениях изученными медицинскими терминами. Эти упражнения по английскому языку закрепляют правильное использование понятий фармакологического регулирования.

Complete the sentences with the words from the box
regulatory approval · breakthrough designation · black box warning · surrogate endpoint · pharmacovigilance · post-marketing surveillance · marketing authorization · advisory committee · biosimilar · label indication · regulatory agency · accelerated approval
- Securing full ____ from the FDA requires extensive clinical trial data.
- The pharmaceutical company applied for European ____ last month.
- The British ____ requested additional safety updates on the biologic.
- The drug was granted ____ to expedite access for severe oncology patients in Chicago.
- FDA ____ helped fast-track the novel Alzheimer's treatment.
- An independent ____ will meet in Baltimore to vote on the safety profile.
- Biomarker reduction served as the primary ____ in the pivotal trial.
- Rigorous ____ in New York hospitals tracked rare adverse events.
- The prominent ____ alerted clinicians to severe hepatic risks.
- Expanding the official ____ will allow physicians to treat earlier stages.
- Robust ____ systems across the United States monitor long-term safety.
- The new ____ offers a cost-effective alternative in Boston clinics.
Sources: photo by Arina Krasnikova on Pexels
Despre această lecție
Acest curs de engleză medicală la nivel avansat (C1-C2) se adresează medicilor consultanți, profesorilor și cercetătorilor care colaborează cu instituții din SUA și Marea Britanie. Lecția de astăzi explorează procesul complex de aprobare a unui medicament inovator și deciziile etice aferente.
Об этом уроке
Этот урок продвинутого уровня английского языка (C1-C2) предназначен для врачей-консультантов, преподавателей и исследователей, сотрудничающих с учреждениями США и Великобритании. На уроке рассматривается сложный процесс одобрения инновационного препарата и связанные с ним этические решения.